In vitro performance assessment of new brushite-forming Zn- and ZnSr-substituted β-TCP bone cements

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 94, Issue 2, 2010, Pages 414-420

  Pina, S ^a   Vieira, S I ^b   Torres, P M C ^a   Goetz Neunhoeffer, F ^c   Neubauer, J ^c   Da Cruz E Silva, O A B ^b   Da Cruz E Silva, E F ^b   Ferreira, J M F ^a  

^a UNIVERSITY OF AVEIRO   (Portugal)

^b UNIVERSITY OF AVEIRO   (Portugal)

^c UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Brushite cement; Cytotoxicity; Mechanical strength; Setting time

Indexed keywords

BONE; CELL CULTURE; CEMENTS; RIETVELD ANALYSIS; RIETVELD METHOD; RIETVELD REFINEMENT; SETTING; X RAY POWDER DIFFRACTION; ZINC;

BIOLOGICAL RESPONSE; BRUSHITE; BRUSHITE CEMENT; CEMENT PASTE; CEMENT POWDER; HUMAN OSTEOSARCOMA; IN-VITRO; MECHANICAL STRENGTH; MG63 CELLS; NON-TOXICITY; PBS SOLUTION; PERFORMANCE ASSESSMENT; POWDERED SAMPLES; QUANTITATIVE PHASE ANALYSIS; RESAZURIN; SETTING TIME; STRUCTURAL REFINEMENT; WET STRENGTH;

BONE CEMENT;

BONE CEMENT; CALCIUM PHOSPHATE; CALCIUM PHOSPHATE DIBASIC; STRONTIUM; UNCLASSIFIED DRUG; ZINC; ZINC STRONTIUM; BETA-TRICALCIUM PHOSPHATE; CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE;

ARTICLE; BIOMECHANICS; CONTROLLED STUDY; HUMAN; HUMAN CELL; MATERIALS TESTING; QUANTITATIVE ANALYSIS; TOXICITY TESTING; X RAY POWDER DIFFRACTION; CHEMISTRY; OSTEOSARCOMA; PATHOLOGY; TOXICITY; TUMOR CELL LINE;

BONE CEMENTS; CALCIUM PHOSPHATES; CELL LINE, TUMOR; HUMANS; MATERIALS TESTING; OSTEOSARCOMA; STRONTIUM; TOXICITY TESTS; ZINC;

EID: 77955355856     PISSN: 15524973     EISSN: 15524981     Source Type: Journal    
DOI: 10.1002/jbm.b.31669     Document Type: Article

References (42)

1. Brown WE, Chow LC. A new calcium-phosphate setting cement. J Dental Res 1983;62:672-672.
2. Wang XP, Ye JD, Wang H. Effects of additives on the rheological properties and injectability of a calcium phosphate bone substitute material. J Biomed Mater Res Part B 2006;78:259-264.
3. Yuan HP, Li YB, De Bruijn JD, De Groot K, Zhang XD. Tissue responses of calcium phosphate cement: A study in dogs. Biomaterials 2000;21:1283-1290.
4. Alves HLR, Dos Santos LA, Bergmann CP. Injectability evaluation of tricalcium phosphate bone cement. J Mater Sci: Mater Med 2008;19:2241-2246.
5. Baroud G, Cayer E, Bohner M. Rheological characterization of concentrated aqueous alpha-tricalcium phosphate suspensions: The effect of liquid-to-powder ratio, milling time, and additives. Acta Biomater 2005;1:357-363.
6. Boesel L, Reis RL. The effect of water uptake on the behaviour of hydrophilic cements in confined environments. Biomaterials 2006;27:5627-5633.
7. Bohner M, Baroud G. Injectability of calcium phosphate pastes. Biomaterials 2005;26:1553-1563.
8. Burguera EF, Xu HHK, Sun LM. Injectable calcium phosphate cement: Effects of powder-to-liquid ratio and needle size 9. J Biomed Mater Res Part B 2008;84:493-502.
9. Gauthier O, Muller R, von Stechow D, Lamy B, Weiss P, Bouler JM, Aguado E, Daculsi G. In vivo bone regeneration with injectable calcium phosphate biomaterial: A three-dimensional microcomputed tomographic, biomechanical and SEM study. Biomaterials 2005;26:5444-5453.
10. Bohner M, Gbureck U. Thermal reactions of brushite cements. J Biomed Mater Res Part B 2008;84:375-385.
11. Hofmann MP, Young AM, Gbureck U, Nazhat SN, Barralet JE. FTIR-monitoring of a fast setting brushite bone cement: Effect of intermediate phases. J Mater Chem 2006;16:3199-3206.
12. Constantz BR, Ison IC, Fulmer MT, Baker J, McKinney LA, Goodman SB, Gunasekaren S, Delaney DC, Ross J, Poser RD. Histological, chemical, and crystallographic analysis of four calcium phosphate cements in different rabbit osseous sites. J Biomed Mater Res Part B 1998;43:451-461.
13. Gisep A, Wieling R, Bohner M, Matter S, Schneider E. Resorption patterns of calcium-phosphate cements in bone. J Biomed Mater Res Part A 2003;66:532-540.
14. Bohner M, Theiss F, Apelt D, Hirsiger W, Houriet R, Rizzoli G, Gnos E, Frei C, Auer JA, von Rechenberg B. Compositional changes of a dicalcium phosphate dihydrate cement after implantation in sheep. Biomaterials 2003;24:3463-3474.
15. Tamimi F, Torres J, Lopez-Cabarcos E, Bassett D, Habibovic P, Luceron E, Barralet JE. Minimally invasive maxillofacial vertical bone augmentation using brushite based cements. Biomaterials 2009;30:208-216.
16. Li X, Sogo Y, Ito A, Mutsuzaki H, Ochiai N, Kobayashi T, Nakamura S, Yamashita K, LeGeros RZ. The optimum zinc content in set calcium phosphate cement for promoting bone formation in vivo. Mater Sci and Eng C 2009.;29:969-975.
17. Marie P, Ammann P, Boivin G, Rey C. Mechanisms of action and therapeutic potential of strontium in bone. Calcif Tissue Int 2001;69:121-129.
18. Dahl S, Allain P, Marie P, Mauras Y, Boivin G, Ammann P, Tsouderos Y, Delmas PD, Christiansen C. Incorporation and distribution of strontium in bone. Bone 2001;28:446-453.
19. Wong CT, Lu WW, Chan WK, Cheung KMC, Lukl KDK, Lu DS, Rabie ABM, Deng LF, Leong JCY. In vivo cancellous bone remodeling on a strontium-containing hydroxyapatite (Sr-HA) bioactive cement. J Biomed Mater Res Part A 2004;68:513-521.
20. Ishikawa K, Miyamoto Y, Yuasa T, Ito A, Nagayama M, Suzuki K. Fabrication of Zn containing apatite cement and its initial evaluation using human osteoblastic cells. Biomaterials 2002;23:423-428.
21. Kannan S, Goetz-Neunhoeffer F, Neubauer J, Ferreira JMF. Synthesis and structure refinement of zinc-doped . J Am Ceram Soc 2009;92:1592-1595.
22. Otsuka M, Marunaka S, Matsuda Y, Ito A, Layrolle P, Naito H, Ichinose N. Calcium level-responsive in vitro zinc release from zinc containing tricalcium phosphate (ZnTCP). J Biomed Mater Res 2000;52:819-824.
23. Rokita E, Hermes C, Nolting HF, Ryczek J. Substitution of calcium by strontium within selected calcium phosphates. J Cryst Growth 1993;130:543-552.
24. Ito A, Ojima K, Naito H, Ichinose N, Tateishi T. Preparation, solubility, and cytocompatibility of zinc-releasing calcium phosphate ceramics. J Biomed Mater Res 2000;50:178-183.
25. Kawamura H, Ito A, Miyakawa S, Layrolle P, Ojima K, Ichinose N, Tateishi T. Stimulatory effect of zinc-releasing calcium phosphate implant on bone formation in rabbit femora. J Biomed Mater Res 2000;50:184-190.
26. Pina S, Olhero SM, Gheduzzi S, Miles AW, Ferreira JMF. Influence of setting liquid composition and liquid-to-powder ratio on properties of a Mg-substituted calcium phosphate cement. Acta Biomater 2009;5:1233-1240.
27. Kannan SFerreira JMF. Synthesis and thermal stability of hydroxyapatite-beta-tricalcium phosphate composites with cosubstituted sodium, magnesium, and fluorine. Chem Mater 2006;18: 198-203.
28. Kannan S, Goetz-Neunhoeffer F, Neubauer J, Ferreira JMF. Ionic substitutions in biphasic hydroxyapatite and beta-tricalcium phosphate mixtures: Structural analysis by Rietveld refinement. J Am Ceram Soc 2008;91:1-12.
29. Kannan S, Pina S, Ferreira JMF. Formation of strontium-stabilized á-tricalcium phosphate from calcium-deficient apatite. J Am Ceram Soc 2006;89:3277-3280.
30. Yashima M, Sakai A, Kamiyama T, Hoshikawa A. Crystal structure analysis of beta-tricalcium phosphate Ca-3(PO4)(2) by neutron powder diffraction. J Sol St Chem 2003;175:272-277.
31. Curry NA, Jones DW. Crystal structure of brushite, calcium hydrogen orthophosphate dihydrate - neutron-diffraction investigation. J Chem Soc 1971;23:3725-3729.
32. Berger G, Ullner C, Neumann G, Marx H. New characterization of setting times of alkali containing calcium phosphate cements by using an automatically working device according to Gillmore needle test. Key Eng Mater 2006;309-311:825-828
33. Chow LC, Hirayama S, Takagi S, Parry E. Diametral tensile strength and compressive strength of a calcium phosphate cement: Effect of applied pressure. J Biomed Mater Res 2000;53:511-517.
34. Gbureck U, Grolms O, Barralet JE, Grover LM, Thull R. Mechanical activation and cement formation of alpha-tricalcium phosphate. Biomaterials 2003;24:4123-4131.
35. Tas AC. Synthesis of biomimetic Ca-hydroxyapatite powders at 37 degrees C in synthetic body fluids 1. Biomaterials 2000;21:1429-1438.
36. Ueno A, Miwa Y, Miyoshi K, Horiguchi T, Inoue H, Ruspita I, Abe K, Yamashita K, Hayashi E, Noma T. Constitutive expression of thrombospondin 1 in MC3T3-E1 osteoblastic cells inhibits mineralization. J Cell Phys 2006;209:322-332.
37. Kannan S, Goetz-Neunhoeffer F, Neubauer J, Rebelo AHS, Valério P, Ferreira JMF. Rietveld structure and in vitro analysis on the influence of magnesium in biphasic (hydroxyapatite and and β-tricalcium phosphate) mixtures. J Biomed Mater Res Part B: Appl Biomater 2009;90:404-411.
38. Bohner M. Calcium orthophosphates in medicine: From ceramics to calcium phosphate cements. Injury-Inter J Care Inj 2000;31:37-47.
39. Gbureck U, Barralet JE, Spatz K, Grover LM, Thull R. Ionic modification of calcium phosphate cement viscosity. Part I: Hypodermic injection and strength improvement of apatite cement. Biomaterials 2004;25:2187-2195.
40. Pina S, Torres PMC, Ferreira JMF. Injectability of brushite-forming Mg-substituted and Sr-substituted α-TCP bone cements. J Mater Sci - Mater Med. 2010;21:431-438.
41. Duck FA. Physical Properties of Tissue: A Comprehensive Reference Book. London: Academic Press Limited; 1990.
42. Pina S, Torres PMC, Goetz-Neunhoeffer F, Neubauer J, Ferreira JMF. Newly developed Sr-substituted α-TCP bone cements. Acta Biomater. 2010;6:928-935.